← Eichor
Condition: Hpv Human Papillomavirus Associated Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hpv Human Papillomavirus Associated

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Phase N/A · 3 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04564989
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Phase 1 · 1 location(s) · Ryan Carey · NCT06747390
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06984861
Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide C
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06821243
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05491512
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Phase 3 · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04178174
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT03875716
Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
Phase 1 · 1 location(s) · BlueSky Immunotherapies GmbH · NCT06589609
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Co
Phase N/A · 1 location(s) · Mayo Clinic · NCT06115772
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subject
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06223568
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Phase N/A · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT05774561
A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Phase 1/Phase 2 · 2 location(s) · Cellid Co., Ltd. · NCT06797986
Merck IIT: RRP Pembro and Lenvatinib
Phase 2 · 1 location(s) · Yale University · NCT04645602
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Phase 2 · 5 location(s) · Vastra Gotaland Region · NCT06793410
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626
Parent Education About Human Papillomavirus (HPV)
NA · 1 location(s) · KTO Karatay University · NCT07447245
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT06686043
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06544720
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05985681
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
NA · 1 location(s) · Ufuk University · NCT07320157
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Phase 1/Phase 2 · 4 location(s) · Theravectys S.A. · NCT06319963
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.